Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure was processed by Pulse News Wire. It represents a primary source document for Japanese equity sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Renascience Inc. (4889): Issues 1,712 Stock Warrants
Source disclosure: March 05, 2026, 15:45 JST
Published by Pulse News Wire: March 05, 2026, 15:58 JST
Renascience Inc. [4889.T]
TOKYO, Mar 05 (Pulse News Wire) – Renascience Inc. (4889) announced a third-party allotment of stock warrants. KEY TERMS: - Warrants to be issued: 1,712 - Shares per warrant: 100 - Maximum dilution: 171,200 shares - Gross proceeds: ¥457 million - Allocation date: 2026-03-05
AI-translated content. 🟢 Confidence: High See terms • Original filing
?
Source disclosure: March 05, 2026, 15:45 JST Published by Pulse News Wire: March 05, 2026, 15:58 JST
TOKYO, Mar 05 (Pulse News Wire) – Renascience Inc. (4889) announced a third-party allotment of stock warrants. KEY TERMS: - Warrants to be issued: 1,712 - Shares per warrant: 100 - Maximum dilution: 171,200 shares - Gross proceeds: ¥457 million - Allocation date: 2026-03-05
